Want to see RVP full AI Analyst Report?
RVP Stock Chart & Stats
$0.73
$0.00(0.00%)
At close: 4:00 PM EDT
$0.73
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.60 - $1.14
Previous Close$0.68
Volume5.56K
Average Volume (3M)20.05K
Market Cap
$20.68M
Enterprise Value-$17.26M
Total Cash (Recent Filing)$39.87M
Total Debt (Recent Filing)$715.92K
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding29,937,159
10 Day Avg. Volume24,252
30 Day Avg. Volume20,050
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap-0.83
Enterprise Value/Revenue-0.51
Enterprise Value/Gross Profit-46.45
Enterprise Value/Ebitda-3.81
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageVery low leverage gives Retractable Technologies meaningful financial flexibility and reduces refinancing risk during periods of weak operations. A sizable equity base can help absorb volatility and preserve room for investment or restructuring while the company works toward restored profitability.
Safety-focused Product PositioningThe company’s focus on safety-engineered syringes and blood-collection products addresses an enduring healthcare workplace-safety need. Products that help reduce needlestick injuries can remain relevant as providers and healthcare systems maintain safety standards and compliance priorities.
Narrowing Net LossesA material reduction in net losses is an initial sign that operating performance may be moving in the right direction, even though profitability has not been achieved. If sustained, further loss reduction could improve capital preservation and strengthen the path toward eventual earnings stability.
Bears Say
Declining RevenueRevenue contraction indicates weaker sales momentum and limits the company’s ability to spread fixed costs across a larger business base. Continued top-line pressure could reduce operating leverage, constrain investment capacity, and make a durable return to profitability more difficult.
Persistent Cash BurnNegative operating and free cash flow show that the business is not currently funding itself through operations. Persistent cash burn can consume financial resources, restrict strategic flexibility, and increase dependence on the balance sheet while management addresses weak earnings and revenue trends.
Weak Operating ProfitabilityNear-breakeven gross margin combined with sizable operating losses points to limited earnings resilience. Without sustained margin improvement, additional revenue may not translate efficiently into profit, leaving the company exposed to continued cost and pricing pressure over the coming quarters.
Retractable Technologies News
RVP FAQ
What was Retractable Technologies’s price range in the past 12 months?
Retractable Technologies lowest stock price was $0.60 and its highest was $1.14 in the past 12 months.
What is Retractable Technologies’s market cap?
Retractable Technologies’s market cap is $20.68M.
When is Retractable Technologies’s upcoming earnings report date?
Retractable Technologies’s upcoming earnings report date is Nov 17, 2026 which is in 38 days.
How were Retractable Technologies’s earnings last quarter?
Retractable Technologies released its earnings results on Aug 14, 2026. The company reported $0.093 earnings per share for the quarter.
Is Retractable Technologies overvalued?
According to Wall Street analysts Retractable Technologies’s price is currently Overvalued.
Does Retractable Technologies pay dividends?
Retractable Technologies does not currently pay dividends.
What is Retractable Technologies’s EPS estimate?
Retractable Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Retractable Technologies have?
Retractable Technologies has 29,937,159 shares outstanding.
What happened to Retractable Technologies’s price movement after its last earnings report?
Retractable Technologies reported an EPS of $0.093 in its last earnings report. Following the earnings report the stock price went up 1.156%.
Which hedge fund is a major shareholder of Retractable Technologies?
Currently, no hedge funds are holding shares in RVP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Retractable Technologies
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Technical Analysis
Ownership Overview
55.66% Insiders
2.55% Mutual Funds
0.19% Other Institutional Investors
39.44% Public Companies and
Individual Investors